A New Route for Tackling Treatment-Resistant Prostate Cancer (IMAGE)
Caption
Scientists have identified what may be the Peyton Manning of prostate cancer. It’s a protein called paxillin that’s essential for the disease to execute its game plan – grow and spread throughout the body. In a study published in the Journal of Clinical Investigation, scientists found that paxillin controls cell growth in tumors that are sensitive to hormone therapy and in tumors that grow resistant to such treatment. Paxillin may be a new treatment target for men with advanced prostate cancer, a stage of the disease which usually proves lethal. Paxillin, in red, is much more prevalent in prostate cancer cells than normal prostate cells.
Credit
University of Rochester Medical Center
Usage Restrictions
Credit required
License
Licensed content